(COVID Version) Global Biologics and Biosimilars Market Status (2016-2020) and Forecast (2021E-2026F) by Region, Product Type & End-Use

November 2021 | 102 pages | ID: CAD7733B61A5EN
99Strategy

Abstracts

SUMMARY

A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original “innovator” products, and can be manufactured when the original product's patent expires.

The report forecast global Biologics and Biosimilars market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021E-2026F due to coronavirus situation.

The report offers detailed coverage of Biologics and Biosimilars industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Biologics and Biosimilars by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

First, this report covers the present status and the future prospects of the global Biologics and Biosimilars market for 2016-2025.

And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].

At the same time, we classify Biologics and Biosimilars according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.

Finally, the report provides detailed profile and data information analysis of leading Biologics and Biosimilars company.

Key Content of Chapters as follows (Including and can be customized) :

Part 1:

Market Overview, Development, and Segment by Type, Application & Region

Part 2:

Company information, Sales, Cost, Margin etc.

Part 3:

Global Market by company, Type, Application & Geography

Part 4:

Asia-Pacific Market by Type, Application & Geography

Part 5:

Europe Market by Type, Application & Geography

Part 6:

North America Market by Type, Application & Geography

Part 7:

South America Market by Type, Application & Geography

Part 8:

Middle East & Africa Market by Type, Application & Geography

Part 9:

Market Features

Part 10:

Investment Opportunity

Part 11:

Conclusion

Market Segment as follows:

By Region

• Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
• Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
• North America[United States, Canada, Mexico]
• Middle East & Africa[GCC, North Africa, South Africa]
• South America[Brazil, Argentina, Columbia, Chile, Peru]

Key Companies

• Roche
• Amgen
• AbbVie
• Sanofi-Aventis
• Johnson & Johnson
• Pfizer
• Novo Nordisk
• Eli Lilly
• Novartis
• Merck
• 3sbio
• Changchun High Tech
• CP Guojian
• Biotech
• Gelgen
• Innovent
• Dong Bao
• Ganlee
• United Laboratories

Market by Type

• Antibody
• Hormone
• Growth Factors
• Others

Market by Application

• Tumor
• Diabetes
• Cardiovascular
• Hemophilia
• Others

Contents

PART 1 MARKET OVERVIEW

1.1 Market Definition
1.2 Market Development
  1.2.1 Current Situation
  1.2.2 Aspects of COVID-19 Impact
1.3 By Type
Table Type of Biologics and Biosimilars
Figure Global Biologics and Biosimilars Market Share by Type in 2020
1.4 By Application
Table Application of Biologics and Biosimilars
Figure Global Biologics and Biosimilars Market Share by Application in 2020
1.5 By Region
Figure Global Biologics and Biosimilars Market Share by Region in 2020
Figure Asia Biologics and Biosimilars Market Share by Region in 2020

PART 2 KEY COMPANIES

2.1 Roche
  2.1.1 Company Profile
Table Roche Overview List
  2.1.2 Products & Services Overview
  2.1.3 Sales Data List
Table Biologics and Biosimilars Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
2.2 Amgen
2.3 AbbVie
2.4 Sanofi-Aventis
2.5 Johnson & Johnson
2.6 Pfizer
2.7 Novo Nordisk
2.8 Eli Lilly
2.9 Novartis
2.10 Merck
2.11 3sbio
2.12 Changchun High Tech
2.13 CP Guojian
2.14 Biotech
2.15 Gelgen
2.16 Innovent
2.17 Dong Bao
2.18 Ganlee
2.19 United Laboratories

PART 3 GLOBAL MARKET STATUS AND FUTURE FORECAST

3.1 Global Market by Region
Table Global Biologics and Biosimilars Market by Region, 2016-2020 (Million USD)
Figure Global Biologics and Biosimilars Market Share by Region in 2020 (Million USD)
Table Global Biologics and Biosimilars Market by Region, 2016-2020 (Volume)
Figure Global Biologics and Biosimilars Market Share by Region in 2020 (Volume)
Table Price List by Region, 2016-2020
3.2 Global Market by Company
Table Global Biologics and Biosimilars Market by Company, 2016-2020 (Million USD)
Figure Global Biologics and Biosimilars Market Share by Company in 2020 (Million USD)
Table Global Biologics and Biosimilars Market by Company, 2016-2020 (Volume)
Figure Global Biologics and Biosimilars Market Share by Company in 2020 (Volume)
Table Price List by Company, 2016-2020
3.3 Global Market by Type
Table Global Biologics and Biosimilars Market by Type, 2016-2020 (Million USD)
Figure Global Biologics and Biosimilars Market Share by Type in 2020 (Million USD)
Table Global Biologics and Biosimilars Market by Type, 2016-2020 (Volume)
Figure Global Biologics and Biosimilars Market Share by Type in 2020 (Volume)
Table Price List by Type, 2016-2020
3.4 Global Market by Application
Table Global Biologics and Biosimilars Market by Application, 2016-2020 (Million USD)
Figure Global Biologics and Biosimilars Market Share by Application in 2020 (Million USD)
Table Global Biologics and Biosimilars Market by Application, 2016-2020 (Volume)
Figure Global Biologics and Biosimilars Market Share by Application in 2020 (Volume)
Table Price List by Application, 2016-2020
3.5 Global Market by Forecast
Figure Global Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Global Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)

PART 4 ASIA-PACIFIC MARKET STATUS AND FUTURE FORECAST

4.1 Asia-Pacific Market by Type
Table Asia-Pacific Biologics and Biosimilars Market by Type, 2016-2020 (Million USD)
Figure Asia-Pacific Biologics and Biosimilars Market Share by Type in 2020 (Million USD)
Table Asia-Pacific Biologics and Biosimilars Market by Type, 2016-2020 (Volume)
Figure Asia-Pacific Biologics and Biosimilars Market Share by Type in 2020 (Volume)
Table Price List by Type, 2016-2020
4.2 Asia-Pacific Market by Application
Table Asia-Pacific Biologics and Biosimilars Market by Application, 2016-2020 (Million USD)
Figure Asia-Pacific Biologics and Biosimilars Market Share by Application in 2020 (Million USD)
Table Asia-Pacific Biologics and Biosimilars Market by Application, 2016-2020 (Volume)
Figure Asia-Pacific Biologics and Biosimilars Market Share by Application in 2020 (Volume)
Table Price List by Application, 2016-2020
4.3 Asia-Pacific Market by Geography
  4.3.1 China Market Status and Future Forecast
Figure China Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure China Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure China Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure China Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
  4.3.2 Southeast Asia Market Status and Future Forecast
Figure Southeast Asia Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Southeast Asia Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure Southeast Asia Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Southeast Asia Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
  4.3.3 India Market Status and Future Forecast
Figure India Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure India Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure India Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure India Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
  4.3.4 Japan Market Status and Future Forecast
Figure Japan Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Japan Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure Japan Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Japan Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
  4.3.5 Korea Market Status and Future Forecast
Figure Korea Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Korea Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure Korea Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Korea Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
  4.3.6 Oceania Market Status and Future Forecast
Figure Oceania Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Oceania Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure Oceania Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Oceania Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
4.4 Asia-Pacific Market by Forecast
Figure Asia-Pacific Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Asia-Pacific Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)

PART 5 EUROPE MARKET STATUS AND FUTURE FORECAST

5.1 Europe Market by Type
Table Europe Biologics and Biosimilars Market by Type, 2016-2020 (Million USD)
Figure Europe Biologics and Biosimilars Market Share by Type in 2020 (Million USD)
Table Europe Biologics and Biosimilars Market by Type, 2016-2020 (Volume)
Figure Europe Biologics and Biosimilars Market Share by Type in 2020 (Volume)
Table Price List by Type, 2016-2020
5.2 Europe Market by Application
Table Europe Biologics and Biosimilars Market by Application, 2016-2020 (Million USD)
Figure Europe Biologics and Biosimilars Market Share by Application in 2020 (Million USD)
Table Europe Biologics and Biosimilars Market by Application, 2016-2020 (Volume)
Figure Europe Biologics and Biosimilars Market Share by Application in 2020 (Volume)
Table Price List by Application, 2016-2020
5.3 Europe Market by Geography
  5.3.1 Germany Market Status and Future Forecast
Figure Germany Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Germany Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure Germany Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Germany Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
  5.3.2 UK Market Status and Future Forecast
Figure UK Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure UK Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure UK Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure UK Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
  5.3.3 France Market Status and Future Forecast
Figure France Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure France Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure France Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure France Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
  5.3.4 Italy Market Status and Future Forecast
Figure Italy Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Italy Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure Italy Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Italy Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
  5.3.5 Russia Market Status and Future Forecast
Figure Russia Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Russia Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure Russia Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Russia Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
  5.3.6 Spain Market Status and Future Forecast
Figure Spain Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Spain Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure Spain Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Spain Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
  5.3.6 Netherlands Market Status and Future Forecast
Figure Netherlands Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Netherlands Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure Netherlands Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Netherlands Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
  5.3.7 Turkey Market Status and Future Forecast
Figure Turkey Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Turkey Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure Turkey Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Turkey Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
  5.3.6 Switzerland Market Status and Future Forecast
Figure Switzerland Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Switzerland Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure Switzerland Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Switzerland Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
5.4 Europe Market by Forecast
Figure Europe Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Europe Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)

PART 6 NORTH AMERICA MARKET STATUS AND FUTURE FORECAST

6.1 North America Market by Type
Table North America Biologics and Biosimilars Market by Type, 2016-2020 (Million USD)
Figure North America Biologics and Biosimilars Market Share by Type in 2020 (Million USD)
Table North America Biologics and Biosimilars Market by Type, 2016-2020 (Volume)
Figure North America Biologics and Biosimilars Market Share by Type in 2020 (Volume)
Table Price List by Type, 2016-2020
6.2 North America Market by Application
Table North America Biologics and Biosimilars Market by Application, 2016-2020 (Million USD)
Figure North America Biologics and Biosimilars Market Share by Application in 2020 (Million USD)
Table North America Biologics and Biosimilars Market by Application, 2016-2020 (Volume)
Figure North America Biologics and Biosimilars Market Share by Application in 2020 (Volume)
Table Price List by Application, 2016-2020
6.3 North America Market by Geography
  6.3.1 United States Market Status and Future Forecast
Figure United States Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure United States Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure United States Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure United States Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
  6.3.2 Canada Market Status and Future Forecast
Figure Canada Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Canada Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure Canada Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Canada Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
  6.3.3 Mexico Market Status and Future Forecast
Figure Mexico Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Mexico Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure Mexico Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Mexico Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
6.4 North America Market by Forecast
Figure North America Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure North America Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)

PART 7 SOUTH AMERICA MARKET STATUS AND FUTURE FORECAST

7.1 South America Market by Type
Table South America Biologics and Biosimilars Market by Type, 2016-2020 (Million USD)
Figure South America Biologics and Biosimilars Market Share by Type in 2020 (Million USD)
Table South America Biologics and Biosimilars Market by Type, 2016-2020 (Volume)
Figure South America Biologics and Biosimilars Market Share by Type in 2020 (Volume)
Table Price List by Type, 2016-2020
7.2 South America Market by Application
Table South America Biologics and Biosimilars Market by Application, 2016-2020 (Million USD)
Figure South America Biologics and Biosimilars Market Share by Application in 2020 (Million USD)
Table South America Biologics and Biosimilars Market by Application, 2016-2020 (Volume)
Figure South America Biologics and Biosimilars Market Share by Application in 2020 (Volume)
Table Price List by Application, 2016-2020
7.3 South America Market by Geography
  7.3.1 Brazil Market Status and Future Forecast
Figure Brazil Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Brazil Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure Brazil Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Brazil Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
  7.3.2 Argentina Market Status and Future Forecast
Figure Argentina Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Argentina Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure Argentina Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Argentina Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
  7.3.3 Columbia Market Status and Future Forecast
Figure Columbia Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Columbia Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure Columbia Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Columbia Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
  7.3.4 Chile Market Status and Future Forecast
Figure Chile Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Chile Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure Chile Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Chile Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
  7.3.5 Peru Market Status and Future Forecast
Figure Peru Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Peru Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure Peru Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Peru Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
7.4 South America Market by Forecast
Figure South America Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure South America Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)

PART 8 MIDDLE EAST & AFRICA MARKET STATUS AND FUTURE FORECAST

8.1 Middle East & Africa Market by Type
Table Middle East & Africa Biologics and Biosimilars Market by Type, 2016-2020 (Million USD)
Figure Middle East & Africa Biologics and Biosimilars Market Share by Type in 2020 (Million USD)
Table Middle East & Africa Biologics and Biosimilars Market by Type, 2016-2020 (Volume)
Figure Middle East & Africa Biologics and Biosimilars Market Share by Type in 2020 (Volume)
Table Price List by Type, 2016-2020
8.2 Middle East & Africa Market by Application
Table Middle East & Africa Biologics and Biosimilars Market by Application, 2016-2020 (Million USD)
Figure Middle East & Africa Biologics and Biosimilars Market Share by Application in 2020 (Million USD)
Table Middle East & Africa Biologics and Biosimilars Market by Application, 2016-2020 (Volume)
Figure Middle East & Africa Biologics and Biosimilars Market Share by Application in 2020 (Volume)
Table Price List by Application, 2016-2020
8.3 Middle East & Africa Market by Geography
  8.3.1 GCC Market Status and Future Forecast
Figure GCC Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure GCC Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure GCC Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure GCC Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
  8.3.2 North Africa Market Status and Future Forecast
Figure North Africa Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure North Africa Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure North Africa Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure North Africa Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
  8.3.3 South Africa Market Status and Future Forecast
Figure South Africa Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure South Africa Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure South Africa Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure South Africa Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
8.4 Middle East & Africa Market by Forecast
Figure Middle East & Africa Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Middle East & Africa Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)

PART 9 MARKET FEATURES

9.1 Product Features
9.2 Price Features
9.3 Channel Features
9.4 Purchasing Features

PART 10 INVESTMENT OPPORTUNITY

10.1 Regional Investment Opportunity
10.2 Industry Investment Opportunity

PART 11 CORONAVIRUS IMPACT

11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment

PART 12 CONCLUSION

List Of Tables

LIST OF TABLES
Table Type of Biologics and Biosimilars
Table Application of Biologics and Biosimilars
Table Roche Overview List
Table Biologics and Biosimilars Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Life & Medical Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Business Operation of AbbVie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Volume Business Operation of Sanofi-Aventis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table xxx Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table xx% Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table 9 Business Operation of Novo Nordisk (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table 2 Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table 0 Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table 3 Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table 1800 Business Operation of 3sbio (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table 2160 Business Operation of Changchun High Tech (Sales Revenue, Cost, Gross Margin)
Table 2810 Business Operation of CP Guojian (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table 76 Business Operation of Biotech (Sales Revenue, Cost, Gross Margin)
Table Business Operation of Gelgen (Sales Revenue, Cost, Gross Margin)
Table A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.A biosimilar in this report is a biologic medical product which is copy of an original product that is manufactured by a different company. Biosimilars are officially approved versions of original “innovator” products, and can be manufactured when the original product's patent expires. Business Operation of Innovent (Sales Revenue, Cost, Gross Margin)
Table Business Operation of Dong Bao (Sales Revenue, Cost, Gross Margin)
Table Business Operation of Ganlee (Sales Revenue, Cost, Gross Margin)
Table Business Operation of United Laboratories (Sales Revenue, Cost, Gross Margin)
Table Global Biologics and Biosimilars Market by Region, 2016-2020 (Million USD)
Table Global Biologics and Biosimilars Market by Region, 2016-2020 (Volume)
Table Price List by Region, 2016-2020
Table Global Biologics and Biosimilars Market by Company, 2016-2020 (Million USD)
Table Global Biologics and Biosimilars Market by Company, 2016-2020 (Volume)
Table Price List by Company, 2016-2020
Table Global Biologics and Biosimilars Market by Type, 2016-2020 (Million USD)
Table Global Biologics and Biosimilars Market by Type, 2016-2020 (Volume)
Table Price List by Type, 2016-2020
Table Global Biologics and Biosimilars Market by Application, 2016-2020 (Million USD)
Table Global Biologics and Biosimilars Market by Application, 2016-2020 (Volume)
Table Price List by Application, 2016-2020
Table Asia-Pacific Biologics and Biosimilars Market by Type, 2016-2020 (Million USD)
Table Asia-Pacific Biologics and Biosimilars Market by Type, 2016-2020 (Volume)
Table Price List by Type, 2016-2020
Table Asia-Pacific Biologics and Biosimilars Market by Application, 2016-2020 (Million USD)
Table Asia-Pacific Biologics and Biosimilars Market by Application, 2016-2020 (Volume)
Table Price List by Application, 2016-2020
Table Europe Biologics and Biosimilars Market by Type, 2016-2020 (Million USD)
Table Europe Biologics and Biosimilars Market by Type, 2016-2020 (Volume)
Table Price List by Type, 2016-2020
Table Europe Biologics and Biosimilars Market by Application, 2016-2020 (Million USD)
Table Europe Biologics and Biosimilars Market by Application, 2016-2020 (Volume)
Table Price List by Application, 2016-2020
Table North America Biologics and Biosimilars Market by Type, 2016-2020 (Million USD)
Table North America Biologics and Biosimilars Market by Type, 2016-2020 (Volume)
Table Price List by Type, 2016-2020
Table North America Biologics and Biosimilars Market by Application, 2016-2020 (Million USD)
Table North America Biologics and Biosimilars Market by Application, 2016-2020 (Volume)
Table Price List by Application, 2016-2020
Table South America Biologics and Biosimilars Market by Type, 2016-2020 (Million USD)
Table South America Biologics and Biosimilars Market by Type, 2016-2020 (Volume)
Table Price List by Type, 2016-2020
Table South America Biologics and Biosimilars Market by Application, 2016-2020 (Million USD)
Table South America Biologics and Biosimilars Market by Application, 2016-2020 (Volume)
Table Price List by Application, 2016-2020
Table Middle East & Africa Biologics and Biosimilars Market by Type, 2016-2020 (Million USD)
Table Middle East & Africa Biologics and Biosimilars Market by Type, 2016-2020 (Volume)
Table Price List by Type, 2016-2020
Table Middle East & Africa Biologics and Biosimilars Market by Application, 2016-2020 (Million USD)
Table Middle East & Africa Biologics and Biosimilars Market by Application, 2016-2020 (Volume)
Table Price List by Application, 2016-2020

List Of Figures

LIST OF FIGURES
Figure Global Biologics and Biosimilars Market Share by Type in 2020
Figure Global Biologics and Biosimilars Market Share by Application in 2020
Figure Global Biologics and Biosimilars Market Share by Region in 2020
Figure Asia Biologics and Biosimilars Market Share by Region in 2020
Figure Global Biologics and Biosimilars Market Share by Region in 2020 (Million USD)
Figure Global Biologics and Biosimilars Market Share by Region in 2020 (Volume)
Figure Global Biologics and Biosimilars Market Share by Company in 2020 (Million USD)
Figure Global Biologics and Biosimilars Market Share by Company in 2020 (Volume)
Figure Global Biologics and Biosimilars Market Share by Type in 2020 (Million USD)
Figure Global Biologics and Biosimilars Market Share by Type in 2020 (Volume)
Figure Global Biologics and Biosimilars Market Share by Application in 2020 (Million USD)
Figure Global Biologics and Biosimilars Market Share by Application in 2020 (Volume)
Figure Global Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Global Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
Figure Asia-Pacific Biologics and Biosimilars Market Share by Type in 2020 (Million USD)
Figure Asia-Pacific Biologics and Biosimilars Market Share by Type in 2020 (Volume)
Figure Asia-Pacific Biologics and Biosimilars Market Share by Application in 2020 (Million USD)
Figure Asia-Pacific Biologics and Biosimilars Market Share by Application in 2020 (Volume)
Figure China Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure China Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure China Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure China Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
Figure Southeast Asia Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Southeast Asia Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure Southeast Asia Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Southeast Asia Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
Figure India Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure India Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure India Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure India Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
Figure Japan Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Japan Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure Japan Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Japan Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
Figure Korea Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Korea Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure Korea Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Korea Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
Figure Oceania Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Oceania Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure Oceania Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Oceania Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
Figure Asia-Pacific Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Asia-Pacific Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
Figure Europe Biologics and Biosimilars Market Share by Type in 2020 (Million USD)
Figure Europe Biologics and Biosimilars Market Share by Type in 2020 (Volume)
Figure Europe Biologics and Biosimilars Market Share by Application in 2020 (Million USD)
Figure Europe Biologics and Biosimilars Market Share by Application in 2020 (Volume)
Figure Germany Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Germany Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure Germany Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Germany Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
Figure UK Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure UK Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure UK Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure UK Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
Figure France Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure France Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure France Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure France Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
Figure Italy Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Italy Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure Italy Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Italy Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
Figure Russia Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Russia Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure Russia Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Russia Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
Figure Spain Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Spain Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure Spain Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Spain Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
Figure Netherlands Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Netherlands Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure Netherlands Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Netherlands Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
Figure Turkey Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Turkey Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure Turkey Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Turkey Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
Figure Switzerland Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Switzerland Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure Switzerland Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Switzerland Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
Figure Europe Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Europe Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
Figure North America Biologics and Biosimilars Market Share by Type in 2020 (Million USD)
Figure North America Biologics and Biosimilars Market Share by Type in 2020 (Volume)
Figure North America Biologics and Biosimilars Market Share by Application in 2020 (Million USD)
Figure North America Biologics and Biosimilars Market Share by Application in 2020 (Volume)
Figure United States Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure United States Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure United States Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure United States Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
Figure Canada Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Canada Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure Canada Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Canada Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
Figure Mexico Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Mexico Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure Mexico Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Mexico Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
Figure North America Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure North America Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
Figure South America Biologics and Biosimilars Market Share by Type in 2020 (Million USD)
Figure South America Biologics and Biosimilars Market Share by Type in 2020 (Volume)
Figure South America Biologics and Biosimilars Market Share by Application in 2020 (Million USD)
Figure South America Biologics and Biosimilars Market Share by Application in 2020 (Volume)
Figure Brazil Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Brazil Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure Brazil Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Brazil Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
Figure Argentina Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Argentina Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure Argentina Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Argentina Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
Figure Columbia Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Columbia Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure Columbia Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Columbia Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
Figure Chile Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Chile Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure Chile Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Chile Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
Figure Peru Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure Peru Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure Peru Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Peru Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
Figure South America Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure South America Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
Figure Middle East & Africa Biologics and Biosimilars Market Share by Type in 2020 (Million USD)
Figure Middle East & Africa Biologics and Biosimilars Market Share by Type in 2020 (Volume)
Figure Middle East & Africa Biologics and Biosimilars Market Share by Application in 2020 (Million USD)
Figure Middle East & Africa Biologics and Biosimilars Market Share by Application in 2020 (Volume)
Figure GCC Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure GCC Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure GCC Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure GCC Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
Figure North Africa Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure North Africa Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure North Africa Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure North Africa Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
Figure South Africa Biologics and Biosimilars Market Market Status, 2016-2020 (Million USD)
Figure South Africa Biologics and Biosimilars Market Market Status, 2016-2020 (Volume)
Figure South Africa Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure South Africa Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)
Figure Middle East & Africa Biologics and Biosimilars Market Forecast, 2021E-2026F (Million USD)
Figure Middle East & Africa Biologics and Biosimilars Market Forecast, 2021E-2026F (Volume)